$37.1MSeries A, 17 November 2025
Funds scale its European infrastructure, current launches and further product alliances and acquisitions.
- Amount
- $37.1M
- Stage
- Series A
- Announced
- 17 November 2025
- Lead
- MVM Partners
- Use of funds
- Funds scale its European infrastructure, current launches and further product alliances and acquisitions.
- Checked
- Announced by the company
- Sources
- Amsterdam's Avanzanite secures 32 million euros to scale rare-disease treatments businesswire.com
Amsterdam's Avanzanite secures 32 million euros to scale rare-disease treatments siliconcanals.com